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Abstract. 
 
It has been proposed that cytoplasmic pep-
tide:
 
N
 
-glycanase (PNGase) may be involved in the pro-
teasome-dependent quality control machinery used to 
degrade newly synthesized glycoproteins that do not 
correctly fold in the ER. However, a lack of informa-
tion about the structure of the enzyme has limited our 
ability to obtain insight into its precise biological func-
tion. A PNGase-defective mutant (
 
png1-1
 
) was identi-
ﬁed by screening a collection of mutagenized strains for 
the absence of PNGase activity in cell extracts. The 
 
PNG1
 
 gene was mapped to the left arm of chromosome 
XVI by genetic approaches and its open reading frame 
was identiﬁed. 
 
PNG1
 
 encodes a soluble protein that, 
when expressed in 
 
Escherichia coli
 
, exhibited PNGase 
activity. 
 
PNG1
 
 may be required for efﬁcient protea-
some-mediated degradation of a misfolded glycopro-
tein. Subcellular localization studies indicate that 
Png1p is present in the nucleus as well as the cytosol. 
Sequencing of expressed sequence tag clones revealed 
that Png1p is highly conserved in a wide variety of eu-
karyotes including mammals, suggesting that the en-
zyme has an important function.
Key words: proteasome • de-
 
N
 
-glycosylation • qual-
ity control
 
Introduction
 
Proteins that transit through the secretory pathway are
subjected to an ER quality control surveillance system
that distinguishes aberrant proteins from folded proteins
so that the former can be retained in the ER (Hammond
and Helenius, 1995). In some cases, it has been shown that
these misfolded and/or unfolded proteins are degraded by
a so-called ER-associated degradation mechanism, which
involves the ubiquitin-proteasome system (Kopito, 1997;
Cresswell and Hughes, 1997; Suzuki et al., 1998a; Brodsky
and McCracken, 1999; Plemper and Wolf, 1999; Römisch,
1999). Characterization of this process is important be-
cause the misfolding and degradation of certain glycopro-
teins causes a number of human genetic disorders.
In mammalian cells, there are examples when de-
 
N
 
-gly-
cosylated intermediates in the overall degradation process
can be detected in the presence of proteasome inhibitors
(Wiertz et al., 1996a,b; Halaban et al., 1997; Hughes et al.,
1997; Huppa and Ploegh, 1997; Yu et al., 1997; Bebök et al.,
1998; de Virgilio et al., 1998; Johnston et al., 1998; Mosse et
al., 1998; Yang et al., 1998). This de-
 
N
 
-glycosylation pro-
cess is catalyzed by the action of a soluble peptide:
 
N
 
-glyca-
nase (EC3.5.1.52; PNGase),
 
1
 
 which is known to occur in
mammalian cells (Suzuki et al., 1993; Kitajima et al., 1995),
hen oviduct (Suzuki et al., 1997), as well as in the budding
yeast, 
 
Saccharomyces cerevisiae 
 
(Suzuki et al., 1998b). PNG-
ase cleaves the amide bond between the proximal 
 
N
 
-acetyl-
glucosamine and the linker asparagine residues on glyco-
peptides/glycoproteins, releasing an intact oligosaccharide
and generating at the site of cleavage an aspartic acid resi-
due in the peptide/protein backbone. PNGase has been
widely used as a tool in studies on N-linked glycan chains.
It has been shown that soluble PNGases have in common
a neutral pH optimum for activity and a requirement for
–SH groups (Suzuki et al., 1994a, 1997, 1998b; Kitajima et
al., 1995). Genes encoding distinct classes of PNGases
 
have been identified in 
 
Chryseobacterium meningosepti-
cum 
 
and 
 
Aspergillus niger
 
 (Tarentino et al., 1990; Ftouhi-
Paquin et al., 1997). These PNGases have no structural ho-
mology with each other; they are secreted and differ from
the ubiquitous intracellular (cytoplasmic) PNGases in
terms of enzymatic properties. Until now, the genes en-
coding the soluble PNGases involved in proteasomal
degradation of proteins in eukaryotes have not been iden-
tified.
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This study describes the PNGase gene (
 
PNG1
 
) from 
 
S
 
.
 
cerevisiae
 
. A PNGase-defective mutant (
 
png1-1
 
) was iden-
tified by screening a collection of temperature-sensitive
mutants for the loss of PNGase activity in cell extracts.
The 
 
PNG1
 
 gene was mapped to the left arm of chromo-
some XVI by genetic approaches. The open reading frame
(ORF) encoding Png1p was determined by performing
PNGase activity assays on extracts derived from individual
yeast strains that had a deletion of a particular ORF in a
known position on chromosome XVI. In this way, one
strain was found that was null in enzyme activity because
it lacked the 
 
PNG1
 
 gene. 
 
PNG1
 
 was found to encode a
42.5-kD soluble protein with no apparent signal sequence.
The 
 
PNG1
 
 gene was demonstrated to encode PNGase by
expression of the enzymatically active protein in 
 
E
 
.
 
 coli
 
.
Although 
 
PNG1
 
 is not an essential gene, it was found to
be required for efficient degradation of a carboxypepti-
dase Y mutant protein that does not undergo folding. Sub-
cellular localization studies indicate that the Png1p is
found in the nucleus, with a lower level occurring in the cy-
toplasm. Comparison of the protein sequences with a vari-
ety of databases, followed by sequencing of a variety of
expressed sequence tag (EST) clones, revealed highly re-
lated genes in humans, mice, plants, fruit flies, nematodes,
and fungi, indicating that this class of PNGase is a highly
conserved enzyme in eukaryotic cells.
 
Materials and Methods
 
Yeast Strains and Media
 
The yeast strains used in this study are listed in Table I. For screening of
the collection of temperature-sensitive strains, 440 previously isolated mu-
tant strains (Hartwell, 1967) were assayed. Unless otherwise noted, 10 ml
of cells were grown at 30
 
8
 
C (or 25
 
8
 
C for temperature-sensitive strains) in
YPAD (1% bacto-yeast extract, 2% bacto-peptone [both from Difco], 2%
dextrose [J.T. Baker], and 40 mg/l adenine sulfate [Sigma Chemical Co.])
in a 50-ml centrifuge tube with shaking. Unless noted, standard yeast me-
dia and genetic techniques were used (Rose et al., 1990; Sherman, 1991;
Elble, 1992).
 
PNGase Activity Assay
 
PNGase activity was assayed in yeast lysates using fetuin-derived asia-
loglycopeptide I ([
 
14
 
C]CH
 
3
 
)
 
2
 
Leu-Asn(GlcNAc
 
5
 
Man
 
3
 
Gal
 
3
 
)-Asp-Ser-Arg)
as described previously (Suzuki et al., 1994a, 1998b). Radioactivity was
monitored on a PhosphorImager (Molecular Dynamics) and quantitated
using ImageQuant (version 1.2). One unit was defined as the amount of
enzyme that catalyzes hydrolysis of 1 
 
m
 
mol of fetuin-derived asialoglyco-
peptide I per minute.
 
Table I. Yeast Strains Used in this Study
 
Strain Genotypes Sources
 
W303-1a MATa 
 
ade2-101 his3-11,15 leu2-3,112 trp1-1 ura3-1 can1-100
 
Laboratory stock
W303-1b MAT
 
a
 
 
 
ade2-101 his3-11,15 leu2-3,112 trp1-1 ura3-1 can1-100
 
Laboratory stock
PS593 MAT
 
a
 
 
 
ade2-1 leu2-3,112 trp1-289 ura3-52
 
P. Sorger
K396-22B MAT
 
a
 
 ade1 his1 leu2 lys7 met3 trp5 ura3 spo11
 
R. Esposito
K393-35C MAT
 
a
 
 
 
his2 leu1 lys1 met4 pet8 ura3 spo11
 
R. Esposito
K382-19D MAT
 
a
 
 
 
ade2 his7 hom3 tyr1 ura3 can1 cyh2 spo11
 
R. Esposito
K381-9D MAT
 
a
 
 
 
ade6 arg4 aro7 asp5 lys2 met14 pet17 trp1 ura3 spo11
 
R. Esposito
BY4742 MAT
 
a
 
 
 
his3
 
D
 
1 leu2
 
D
 
0 lys2
 
D
 
0 ura3
 
D
 
0
 
This study
#2156 MAT
 
a
 
 
 
his3
 
D
 
1 leu2
 
D
 
0 met15
 
D
 
0 ura3
 
D
 
0 png1
 
D
 
::KanMX4
 
Research Genetics
#10568 BY4742
 
 erg6
 
D
 
::KanMX4
 
Research Genetics
#20941 MATa/MAT
 
a
 
 
 
his3
 
D
 
1/his3
 
D
 
1 leu2
 
D
 
0/leu2
 
D
 
0 lys2
 
D
 
0/LYS2 met15
 
D
 
0/MET15 ura3
 
D
 
0/ura3
 
D
 
0 spo11
 
D
 
::KanMX4/SPO11
 
Research Genetics
RSY281 MAT
 
a
 
 
 
sec23-1 ura3-52 his4-619
 
R. Schekman
RSY607 MAT
 
a
 
 
 
leu2,3-112 ura3-52 pep4
 
D
 
::URA3
 
R. Schekman
CY629 MAT
 
a
 
 
 
his3-
 
D
 
200 leu2-
 
D
 
1 trp1-
 
D
 
63 ade-2-101 lys2 hho1
 
D
 
::HIS3 
 
C. Peterson
YEA78 W303-1b 
 
hmr::URA3 
 
D
 
eb::UAS
 
G
 
 gal4
 
D
 
::LEU2
 
R. Sternglanz
YWC2 W303-1a 
 
elp3
 
D
 
::URA3
 
R. Sternglanz
TSY5 MATa 
 
ade2 his3 leu2 trp1 ura3 png1-1
 
This study
TSY9 MAT
 
a
 
 
 
ade2 his3 leu2 trp1 ura3 png1-1 can1
 
This study
TSY41 TSY5 
 
spo11
 
D
 
::ADE2
 
This study
TSY54 TSY41 
 
can1 cyh2
 
This study
TSY75* MAT
 
a
 
 
 
ade6 aro7 lys2 met14 trp1 ura3 sec23-1 (spo11)
 
This study
TSY79 MAT
 
a
 
 
 
ade2 his3 leu2 trp1 ura3 gal4
 
D
 
::LEU2
 
This study
TSY80 MATa 
 
ade2 his3 leu2 trp1 ura3 gal4
 
D
 
::LEU2
 
This study
TSY82 MAT
 
a ade2 his3 leu2 trp1 ura3 gal4
 
D
 
::LEU2 hho1
 
D
 
::HIS3
 
This study
TSY83 MAT
 
a
 
 
 
his3
 
D
 
1 leu2
 
D
 
0 lys2
 
D
 
0 met15
 
D
 
0 ura3
 
D
 
0 spo11
 
D
 
::KanMX4
 
This study
TSY91 MAT
 
a
 
 ade2 his3 leu2 trp1 ura3 can1 gal4
 
D
 
::LEU2 elp3
 
D
 
::URA3
 
This study
TSY94 MAT
 
a
 
 
 
ade2 his3 leu2 ura3 gal4
 
D
 
::LEU2 pep4
 
D
 
::URA3
 
This study
TSY115 #2156 
 
prc1-1
 
This study
TSY146 W303-1a 
 
png1
 
D
 
::his5
 
1
 
(pombe)
 
This study
TSY147 BY4742 
 
prc1-1
 
This study
TSY148 BY4742 
 
prc1-1 erg6
 
D
 
::KanMX4
 
This study
TSY149 BY4742 
 
prc1-1 png1
 
D
 
::KanMX4 This study
TSY150 BY4742 prc1-1 erg6D::KanMX4 png1D::KanMX4 This study
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Chromosomal Identification of png1-1 Locus
To generate TSY41, SPO11 gene disruption of TSY9 was carried out us-
ing SalI-PvuII digests of pME302 (Engebrecht and Roeder, 1989). The
disruption was confirmed by showing that when crossed to a spo11 tester
strain and sporulated, ,1% of the spores were viable. Furthermore, spore
inviability was complemented by the introduction of pGB430 (provided
by Dr. J. Engebrecht, SUNY at Stony Brook) containing the wild-type
SPO11 gene. Chromosomal mapping of png1-1 mutation was performed
using the spo11-mapping method (Klapholz and Esposito, 1982). For
mapping of chromosome XII, TSY83 was prepared by sporulation of Re-
search Genetics strain (No. 20941). CanR and CyhR derivatives of TSY41
cells (TSY54) were isolated by selecting cells on plates containing either
synthetic media –Arg 160 mg/ml canavanine or YPAD 110 mg/ml cyclo-
heximide. The mutants were shown to be mutant for CAN1 and CYH2 by
complementation tests.
Genetic Mapping of png1-1 Locus
TSY75, which carries aro7 and sec23 as markers for the right arm of chro-
mosome XVI, was prepared by crossing RSY281 (a gift from Dr. Randy
Schekman, University of California at Berkeley, Berkeley, CA) with
K398-4D and isolating haploid segregants of the appropriate genotype.
TSY82, which carries hho1D::HIS3 and gal4D::LEU2 as markers on the
left arm of chromosome XVI, was prepared by crossing CY629 with
YEA78 and isolating haploid segregants of the appropriate genotype.
These strains were crossed to png1-1 haploids (TSY5 or TSY9, respec-
tively), and tetrad analysis of the resulting spores determined whether
png1-1 was linked to any of the markers.
To carry out mitotic mapping to determine the proximity of the muta-
tion to known markers, TSY94 (prepared by crossing RSY607; a gift from
Dr. Randy Schekman) with TSY80 and isolating haploid segregants of the
appropriate genotype and TSY91 (prepared by crossing TSY79 with
YWC2 and isolating haploid segregants of the appropriate genotype)
were used. After mating these strains with TSY9, diploids were selected.
The diploids were grown nonselectively overnight at 308C in YPAD and
plated to select for FOAR colonies. Among these, Leu2 cells were assayed
for PNGase activity.
Bacterial Expression of Png1p
DNA manipulations were performed according to Sambrook et al. (1989).
The full-length PNG1 sequence was amplified from yeast chromosomal
DNA using Vent DNA polymerase (New England BioLabs, Inc.) using 59
primer (59-TTTTTCCATGGGAGAGGTATACGAAAAAA-39) and 39
primer (59-TTTTTCTCGAGCTATTTACCATCCTCCCCAC-39). Thus,
the fragment obtained was cut by NcoI-XhoI digestion, and cloned into
NcoI-SalI–digested pET-28b (Novagen, Inc.). For the (His)6 version of
Png1p, another 39 primer (59-TTTTTCTCGAGTTTACCATCCTC-
CCCACGCT-39) was used, and the NcoI-XhoI fragment was cloned into
the pET-28b vector. These constructs were transformed into BL21(DE3)
pLysS cells, and expression of PNG1 was induced by adding 1 mM IPTG
at OD600 5 0.8/ml. After 3 h at 378C, 3 ml of cells were collected and the
protein was extracted by adding 400 ml of PBS/1% Triton containing 5
mM DTT and 1 mM PMSF, followed by sonication on ice using a Branson
sonicator at level 3 for two 10-s intervals with a 1-min wait at 08C between
sonications. The cell extract was centrifuged at 16,000 g for 10 min at 48C,
and the supernatant was assayed for PNGase activity.
Purification of (His)6-tagged Png1p (Png1(His)6p)
The overproduced (His)6-tagged Png1p (Png1(His)6p) in E. coli as de-
scribed above was purified using a TALON metal affinity resin (CLON-
TECH Laboratories, Inc.). The E. coli extract (15 ml) was obtained as de-
scribed above, except that the extract was made in 20 mM Tris-HCl
buffer/1% Triton, pH 7.5, and 1 mM PMSF. Thus, the extract obtained
was incubated at 48C for 2 h with 0.5 ml Talon resin that had been pre-
equilibrated with 20 mM Tris-HCl/100 mM NaCl (binding buffer, pH
7.5). The entire reaction was transferred into a 3-ml gravity flow column,
and the flowthrough fraction (z3 ml) was collected. The resin was further
washed with binding buffer with 10 mM imidazole (4 ml), and then eluted
with binding buffer with 100 mM imidazole (4 ml). Finally, the column
was washed with 40 mM MES-NaOH buffer, pH 5.2. Throughout the col-
umn operation, fractions of 1 ml were collected. During fractionation,
DTT was immediately added to each fraction to a final concentration of
10 mM. Each fraction was analyzed by SDS-PAGE and also was assayed
for PNGase activity. The pure (Png1(His)6p fraction (fraction 8–12) was
collected, concentrated with B88 buffer (20 mM Hepes-KOH buffer, pH
6.8, 150 mM potassium acetate, 5 mM magnesium acetate, and 250 mM
sorbitol) containing 10 mM DTT using a Microcon 10 (Amicon Inc.), and
finally diluted with B88 with 10 mM DTT at a final concentration of 14 mg
protein/ml. The protein concentration was quantitated with the Bio-Rad
protein assay kit.
Product Analysis of Incubation of [14C]Asialofetuin 
Glycopeptide I with Purified Png1(His)6p
Deglycosylation reaction by purified Png1(His)6p was confirmed by prod-
uct analysis using paper chromatography and paper electrophoresis as de-
scribed earlier (Kitajima et al., 1995). [14C]Asialofetuin glycopeptide I
(20,000 dpm) was digested with 12 mU of purified Png1(His)6p, in a 10-ml
reaction with 40 mM MES-NaOH buffer, pH 6.6, with 10 mM DTT at
308C for 15 h. The paper chromatography steps detect the removal of the
glycan from glycopeptide, whereas the paper electrophoresis confirms the
conversion of a glycosylated asparagine residue into an aspartic acid resi-
due (Kitajima et al., 1995). Paper chromatography was carried out using
1-butanol/ethanol/H2O 5 2:1:1 as a solvent (Suzuki et al., 1998b). Paper
electrophoresis was carried out using a model EF-200 unit (Advantec
Toyo Kaisha Ltd.) as described earlier (Suzuki and Lennarz, 2000) and vi-
sualized using a PhosphorImager. Authentic PNGase F-deglycosylated
peptide was prepared by digestion of 20,000 dpm [14C]asialofetuin glyco-
peptide I with 5 units of PNGase F (Roche) in 20 ml of 50 mM Tris-HCl
buffer, pH 8.0, at 378C for 15 h.
Examination of Reactivity of Purified Png1(His)6p 
toward Glycoproteins In Vitro
10 mg each of three glycoproteins, ovalbumin, ribonuclease B, and carboxy-
peptidase Y (Sigma Chemical Co.) was incubated in 20 ml of 40 mM
MES-NaOH buffer, pH 6.6, containing 10 mM DTT with 30 mU of puri-
fied Png1(His)6p at 308C for 15 h. For reference, 10 mg of each glycopro-
tein was digested with 2 ml of PNGase F (a gift from Dr. Robert Haltiwan-
ger, SUNY at Stony Brook) in 20 ml of 50 mM Tris-HCl buffer, pH 8.5, at
378C for 15 h. The reaction mixture was analyzed by 8% (carboxypepti-
dase Y), 10% (ovalbumin) or 15% (ribonuclease B) SDS-PAGE. In one
experiment, glycoproteins were preincubated at 658C for 30 min at a con-
centration of 1 mg/ml before incubation with Png1(His)6p.
Construction of PNG1-containing Plasmids for 
Expression in Yeast
The PNG1 allele including its promoter region was amplified from yeast
genomic DNA using the following primers and Vent DNA polymerase:
59-AAAAAGAATTCCGTACAAACAAGCTAGAG; and 59-AAAA-
ACTCGAGTCACACCAGGCTATGAGGG-39. The fragment obtained
was digested with EcoRI-XhoI, and was cloned into the EcoRI-XhoI site
of pRS316 (Sikorski and Hieter, 1989), or the EcoRI-SalI site of YEp352
(Hill et al., 1993). These plasmids were transformed into a PNG1 deletion
strain (TSY146), and the protein extract was prepared from cells (total
OD600 5 40) by the method described earlier (Suzuki et al., 1998b). The
PNGase activity in each extract was assayed as described above.
For analyzing the mutation in png1-1, genomic DNA was isolated from
TSY5, and the png1-1 allele was isolated by PCR using the same primers
as described above. The fragment obtained was digested with EcoRI-
XhoI, and was cloned into the EcoRI-XhoI site of pBluescript II S/K (1/2)
(Strategene) for sequencing and the EcoRI-SalI site of YEp352 for ex-
pression of this allele in TSY146 cells.
Construction of Carboxypeptidase Mutant (CPY*)
The prc1-1 mutation was introduced into yeast using the two-step gene re-
placement method (Rothstein, 1991). An integrating plasmid containing
prc1-1 was constructed using the PCR mutagenesis technique (Horton et al.,
1990). In brief, the EcoRI-HindIII fragment of pJW1433, which contains
the ORF of wild-type PRC1 (Holst et al., 1996), was cloned into YIp5
(New England Biolab). pJW1433 was a gift from Dr. Jacob Winther
(Carlsberg Laboratory, Copenhagen Valby, Denmark). The following
primers were used to amplify a fragment of PRC1 using pJW1433 as a
template: 59-GGTTACTTGGATGTGGAAGACG-39; 59-CCACATCG-
CTAGGGAATCCTAC-39; 59GTAGGATTCCCTAGCGATGTGG-39;
and 59-CAAAAGATCTGTTACGGCGGTG-39 (underlined letters re-The Journal of Cell Biology, Volume 149, 2000 1042
fer to base change used to generate CPY*). The fragment was digested
with AocI-BglII, and the equivalent fragment on YIp5-CPY was replaced
by the PCR-derived prc1-1 fragment. The sequence was confirmed using
the EXCELII sequencing kit (Epicentre Technologies). The YIp5-CPY*
was cut by AocI and integrated into strains of PRC1 locus. Transformants
were grown nonselectively in YPAD to allow excision of the plasmid and
plated onto FOA plates. The presence of prc1-1 was confirmed by showing
disruption of the BstXI site within the gene using colony PCR as described
before (Jakob et al., 1998). For PCR, the following primers were used: 59-
TTGAAACCCATCGGGAACCC-39  and 59-ACAACGTTCCAAAGG-
GTCTTC-39; and the digests were analyzed in a 2% agarose gel.
Radiolabeling of Cells and Immunoprecipitation
Cells were grown to an OD600 5 1 at 308C in minimal medium without me-
thionine and cysteine. Cells were concentrated to OD600 5 10, and 1-ml al-
iquots were preincubated at 308C for 30 min. During the preincubation,
where indicated, MG-132 (Calbiochem) was added to a final concentra-
tion of 50 mM from a freshly made 5 mM solution in (DMSO). For control
cells, the same amount of DMSO was added. Radiolabeling of the cells
was initiated by the addition of Easy Tag Express-[35S] (43.48 GBq/mmol;
NEN Life Science Products) to 100 mCi/OD600 of cells, and incubation was
continued for 10 min for the prc1-1 strain and 5 min for the PRC1 strain.
A chase mix was added from a 1003 stock solution (0.3% cysteine and
0.4% methionine), and incubation continued. At indicated periods of
time, an equal volume of ice-cold 20 mM NaN3/20 mM Tris-HCl, pH 7.5,
was added to terminate the chase. Protein extracts were prepared and
were immunoprecipitated as described previously (Gillece et al., 1999) us-
ing anti-CPY antiserum (a gift from Dr. Marcus Aebi, ETH, Zürich). Pro-
teins were analyzed on 7.5% polyacrylamide gels. When necessary, immu-
noprecipitated samples were divided into two aliquots; one was treated
with 5 U of PNGase F (Roche) for 16 h at 378C before gel electrophoresis.
Labeled bands were visualized using the PhosphorImager and quantitated
as described above. The cells used for this analysis (TSY147-150) were
made by crossing TSY115 with Research Genetics strain No. 10568 and
isolating haploid segregants of the appropriate genotype.
Western Blot Analysis
Protein extracts (20 mg) from yeast cells were prepared as described (Yan
et al., 1999). Extracts were resolved on 10% SDS-PAGE and transferred
to nitrocellulose membranes. Blots were incubated with a 1:100 dilution of
anti-GFP mAb (CLONTECH Laboratories, Inc.), followed by 1:2,000 di-
lution with the anti-mouse IgG HRP-conjugated secondary antibody
(Roche). Gels were visualized using chemiluminescence (Kpn) after expo-
sure to medical X-ray film (Fuji Photo Film Co.).
Construction of Png1-GFP Fusion Protein and 
Determination of Subcellular Localization of Png1p
A png1D strain in a W303-1a background was made by the one-step PCR-
mediated technique for deletion using the Schizosaccharomyces pombe
his51 gene (Longtine et al., 1998). The pFA6a-His3MX6 was used as a
template and the following primers were used for amplifying the disrup-
tion cassette: 59-AGATATAGAAGACGTAAAACAACCTGAAGA-
AGGTAACAGGTGGAGTAGCACGGATCCCCGGGTTAATTAA-
39; and 59-CTGGTTAACAAAGCAAGCTGCCGAGTTCTTGGGC-
AGC-TTTGATGAGTTAGGAATTCGGGCTCGTTTAAAC-39. The
disruption was verified by PCR as well as by the loss of PNGase activity in
the cell extract.
A plasmid encoding a green fluorescent protein (GFP) fusion at the
COOH terminus of Png1p was made using pGFP-C-FUS plasmid
(Niedenthal et al., 1996), in which the protein can be expressed under the
control of the MET25 promoter. In brief, the XbaI-HindIII fragment from
(His)6-tagged PNG1 in pET-28b was cloned into equivalent sites of the
pGFP-C-FUS plasmid. The fusion protein was expressed in the synthetic
medium -Ura-Met, and 5 ml of logarithmically growing cells (OD600 5
0.6/ml) were fixed for 3 h in the growth medium supplemented with 3.7%
formaldehyde and 40 mM potassium phosphate buffer, pH 6.5, containing
0.5 mM MgCl2. Cells were washed once and resuspended in 0.5 ml of sor-
bitol buffer (1.2 M sorbitol, 40 mM potassium phosphate buffer, pH 6.5,
and 0.5 mM MgCl2). Cell walls were digested for 30 min at room tempera-
ture in sorbitol buffer supplemented with 0.2% b-mercaptoethanol and
30 ml of 10 mg/ml zymolyase-100T (ICN). The resulting spheroplasts were
placed on poly-L-lysine–coated glass slides and mounting media (50 ng/ml
DAPI and 1% p-phenylenediamine in PBS, pH 8.0). Images of GFP fluo-
rescence as well as DAPI staining were captured in Adobe Photoshop
from a SPOT-cooled CCD 24-bit color digital camera (Diagnostic Instru-
ments) mounted on a Zeiss Axioskop 2 microscope using the software
supplied with the SPOT camera.
Determination of PNG1-related Gene Sequences
Sequence similarity searches were performed on the National Center of
Biotechnology Information (NCBI) server (http://www.ncbi.nlm.nih.gov),
the Berkeley Drosophila Genome Project (BDGP) server (http://www.
fruitfly.org), and the C. elegans EST database of the DNA Databank
of Japan (DDBJ; http://www.ddbj.nig.ac.jp/htmls/c-elegans/html/CE_
INDEX.html). Mouse EST clones were first identified (see Table IV)
based on their sequence similarity to the yeast Png1p sequence. One of
these EST clones (AI019191) was sequenced, and the sequences obtained
were used to find other clones. cDNA clones (ID No. 948982, 1316890 and
LD46390) were obtained from Research Genetics; EST (ID 97076) was
obtained from American Type Culture Collection, and the C. elegans EST
clone (yk491h3) was a gift from Dr. Yuji Kohara (National Institute of
Genetics). All EST clones were completely sequenced, and deduced
amino acid sequences were obtained using MacVector (version 6.0). De-
tailed methods can be provided upon request.
Results
Isolation of a PNGase-defective Mutant from a 
Temperature-sensitive Mutant Collection
Earlier we reported that S. cerevisiae has a soluble PNG-
ase activity that is very similar in terms of enzymatic prop-
erties to the soluble PNGases found in higher eukaryotes
(Suzuki et al., 1998b). To identify the PNGase gene in
yeast, mutants defective in PNGase activity were sought.
From a collection of temperature-sensitive mutants, 440
strains were individually assayed for the loss of PNGase
activity (Hartwell, 1967). Among these 440 strains, 10
strains showed virtually no PNGase activity at 378C, the
nonpermissive temperature. These 10 strains were crossed
to an isogenic strain (PS593). The resulting diploids were
dissected and individual spore colonies were assayed for
PNGase activity. One strain (No. 352) was observed to
segregate 21:22 for PNGase activity in this cross (Fig. 1),
demonstrating that the PNGase defect in strain No. 352
was the result of a mutation in a single gene. The PNGase
defect in No. 352 did not cosegregate with the tempera-
ture-sensitive phenotype (data not shown). We named the
mutation in the strain png1-1, after peptide:N-glycanase.
Strains TSY5 and TSY9 (see Table I for a complete strain
list) carrying png1-1 were made by backcrossing strain No.
352 with wild-type strains (one cross with PS593 followed
by four crosses with W303-1 strain), and used for the map-
ping study.
Chromosomal Mapping of png1-1 Mutation
Neither TSY5 nor TSY9 showed any phenotype or growth
defect under various experimental conditions tested, mak-
ing it difficult to clone by complementation. Therefore,
the spo11 mapping technique (Klapholz and Esposito,
1982) was employed to localize the png1-1 mutation onto a
particular chromosome. The rationale behind this ap-
proach takes advantage of the fact that there is no meiotic
recombination in spo11 diploids. Therefore, if a png1
spo11 haploid is crossed to a spo11 strain carrying lys1 on
chromosome IX, for example (thereby producing a diploid
with the parental configuration (png1 LYS1/PNG1 lys1)),Suzuki et al. PNGase Gene in Saccharomyces cerevisiae 1043
recombinant spores (PNG1 LYS1 and png1 lys1) arise pri-
marily by independent assortment during meiosis. The
presence of recombinant spores is, therefore, suggestive
that png1 is not on the marked chromosome. In contrast,
the absence of recombinant types suggests that png1 is lo-
cated on the same chromosome as that marker. Because
spo11 mutants produce predominantly inviable spores,
rare viable spores were first selected on –Arg plates con-
taining canavanine and cycloheximide (Hollingsworth and
Byers, 1989). The spore colonies were patched onto
YPAD plates and replica plated onto the appropriate me-
dia to score the marked chromosomes. PNGase assays
were performed on the spore colonies to determine the
png1 phenotype.
The data in Table II show that the cross between aro7
and png1-1 was the only one to produce a class of no re-
combinant types (png1 aro7). The other seven putative re-
combinants (Tyr1 PNGase1) were demonstrated by fur-
ther genetic analysis to be due to disomy of chromosome
XVI resulting from nondisjunction (data not shown).
Therefore, these results suggested that png1-1 was on
chromosome XVI.
Genetic Mapping of png1-1 Mutation to a Specific Site 
on Chromosome XVI
To localize png1-1 more precisely on chromosome XVI,
png1-1 was crossed to TSY75 and TSY82, both of which
have two markers (ARO7 and SEC23 in TSY75 and HHO1
and GAL4 in TSY82) on chromosome XVI (Fig. 2). Tet-
rad analysis of the sporulated diploids revealed that the
png1-1 mutant was not linked to markers on the right arm,
whereas png1-1 did exhibit linkage to the HHO1 locus, but
not to GAL4, on the left arm (Table III). These results
placed the png1-1 mutation approximately in the middle
region of the left arm on chromosome XVI.
To further narrow down the png1-1 locus, mitotic map-
ping was carried out. This method uses mitotic crossing
over in diploids to determine the order of genes on the
same arm of a chromosome. TSY91 contains URA3 inte-
grated at the ELP3 locus and TSY94 contains URA3 inte-
grated at the PEP4 locus. These strains were crossed to
the png1-1 ura3 haploid TSY5. The diploids were grown
nonselectively and plated on 5-fluoroorotic acid (FOA) to
select for strains exhibiting loss of the URA3 gene. This
loss of heterozygosity results from crossovers between ei-
ther elp3D::URA3 or pep4D::URA3  and centromere. To
ensure that FOAR was due to recombination and not gene
conversion, loss of the gal4D::LEU2 marker on the same
arm distal to elp3D::URA3 and pep4D::URA3 was also re-
Figure 1. Assay of PNGase activity in four sets of tetrads from
the cross of a PNGase-defective mutant (No. 352) with a wild-
type strain (PS593). Protein extracts (z20 mg) from each spore
colony were incubated with 25 mM of [14C]asialofetuin peptide I
in 6 ml of 70 mM Hepes-NaOH buffer, pH 7.2, and 5 mM DTT at
258C for 16 h. The reaction product was analyzed by paper chro-
matography and the radioactive peptides were visualized using a
PhosphorImager. A paper chromatogram of four different tet-
rads (1–4) are shown. P, de-N-glycosylated product ([14C]-Leu-
Asp-Asn-Ser-Arg); and S, substrate ([14C]-Leu-Asn(GlcNAc5
Man3Gal3)-Asn-Ser-Arg).
Table II. Segregation of png1-1 Mutation with Other Markers 
on spo11 Mapping Analysis*
Chromosome 
(marker‡)
Phenotype of spores
Parental 1 Parental 2 Recombinant 1 Recombinant 2
I (ade2) 77 5 1 0
II (lys2)1 48 5 4
III (leu2*) 21 23 12 13
IV (trp1*) 11 20 9 11
V (hom3)N A i 22 NAi 12
VI (his2)67 2 7
VII (cyh2) 2 14 8 11
VIII (arg4§)1 1 6 7 7
IX (lys1)33 5 1 0
X (met3)43 4 3
XI (met14)1 6 4 9 2
XII (met15)2 1 2 3
XIII (lys7)9 9 1 1 6
XIV (met4)1 4 7 1 0
XV (his3*) 26 13 31 14
XVI (aro7)2 3 3 4 7 0
*The results shown were obtained by cross of TSY54 to test strains (K396-22B/K381-
9D/K393-35C/TSY83) except for chromosome V (hom3) and chromosome VII (cyh2),
which were obtained from TSY41 3 K382-19D, selecting spores only using
canavanine.
‡The markers indicated with asterisks were from TSY54, whereas the others were from
the test strains.
§Spores were selected using only cycloheximide.
iNA, not applicable because of the selection method.
Table III. Genetic Mapping of the png1-1 Mutation by
Tetrad Analysis
Cross
Parental
Ditypes
Nonparental 
Ditypes Tetratypes Linkage
png1-1 3 SEC23* 3 4 8 unlinked
png1-1 3 ARO7* 3 4 8 unlinked
png1-1 3 HHO1‡ 15 0 6 14.3 cM
png1-1 3 GAL4‡ 4 2 15 unlinked
*The results shown were obtained by crossing TSY5 with TSY75.
‡The results shown were obtained by crossing TSY9 with TSY82.The Journal of Cell Biology, Volume 149, 2000 1044
quired. All of the FOAR Leu2 colonies derived from the
TSY5/TSY91 diploid were defective for PNGase activity,
indicating that the png1-1 locus is distal to the ELP3 locus.
On the other hand, 4/16 FOAR Leu2 strains were PNG-
ase-positive from the TSY5/TSY94 diploid, indicating that
the png1-1 gene is centromere proximal to the PEP4 locus.
Given that png1-1 is located in between ELP3 and
PEP4, the Saccharomyces Genome database (http://genome-
www.stanford.edu/Saccharomyces/) was analyzed for
ORFs in this interval. Among 67 ORFs, 16 candidate ORFs
were chosen (YPL144w, YPL141c, YPL138c, YPL136w,
YPL116w, YPL113c, YPL110c, YPL108w, YPL107w,
YPL103c, YPL101w, YPL100w, YPL099c, YPL098c,
YPL096w,  and YPL095c). These ORFs were chosen as
potential candidates for PNG1 based on the following cri-
teria: (1) the ORF was uncharacterized; (2) it was at least
20 kb distance from the HHO1 locus (based on tetrad
analysis data); and (3) it encoded a protein with a molecu-
lar mass .12 kD. Strains containing individual deletions of
each ORF were obtained from Research Genetics and as-
sayed biochemically for PNGase activity. A strain deleted
in YPL096w (No. 2156) did not exhibit any PNGase activ-
ity, thereby identifying this ORF as PNG1. To confirm
that png1-1 is the same locus as YPL096w, we crossed the
Research Genetics strain (No. 2156) with the png1-1 hap-
loid, TSY9. After tetrad dissection, 10 tetrads were as-
sayed for PNGase activity; none of the spores exhibited
PNGase activity, as expected if the two mutants are allelic.
Indeed, the sequence analysis of png1-1 allele revealed
that the png1-1 allele was due to a point mutation of resi-
due 218, in which His was mutated to Tyr mutation. The
catalytic inactivity of this mutant protein is consistent with
the fact that this His residue is highly conserved in a vari-
ety of eukaryotic organisms (see below).
PNG1 is predicted to encode a protein (Png1p) with a
molecular mass of 42.5 kD. The protein does not have ei-
ther a predicted signal sequence or a membrane spanning
domain. Png1p does not have any homologues in the S.
cerevisiae genome nor does it exhibit any sequence simi-
larity with known PNGases from a bacterium and a fungus
(Tarentino et al., 1990; Ftouhi-Paquin et al., 1997). How-
ever, a number of related proteins in other eukaryotes, in-
cluding mammalian cells, were identified (see below).
Bacterial Expression of PNG1 Shows that Png1p Is a 
Soluble Enzyme
Although mutation of the PNG1 gene renders yeast cells
devoid of PNGase activity, this result by itself does not dis-
tinguish whether PNG1 encodes the PNGase enzyme or a
regulatory gene required for PNGase activity. Since no
PNGase activity in E. coli extracts was observed under our
experimental conditions, the yeast PNG1 gene was placed
under the T7 expression system, introduced into E. coli,
and the resulting cell extracts were monitored for PNGase
activity. As shown in Fig. 3, expression of PNG1 in BL21
(DE3)pLysS cells with the pET-28b vector resulted in very
high PNGase activity. A similar result was observed in ex-
tracts from E. coli expressing (His6)-tagged PNG1 (data
not shown). The protein was easily recovered from the sol-
uble fractions after cell lysis with 1% Triton in the extrac-
tion buffer followed by centrifugation at 16,000 g.
For the purpose of subsequent product analysis using
glycopeptide/glycoproteins as substrates, purification of
Png1p was performed by using (His6)tag and a (His6)-
tagged protein-specific metal affinity resin. In Fig. 4 (A
and B), the elution profile of the E. coli extract over-
expressing (His6)-tagged Png1p (Png1(His6)p) using a
TALON metal affinity column is shown. The tightly
bound fraction (Fractions 8–12) gave a single protein band
z44 K on SDS-PAGE (Fig. 4 A), which is consistent with
the expected molecular mass of Png1(His6)p. This bound
protein, together with the flowthrough fraction, exhibited
high PNGase activity (Fig. 4 B), which was quantitated by
paper chromatography. The elution pattern of PNGase
correlated with the appearance of the Png1(His6)p band
on the gel (Fig. 4, A and B). The purified protein exhibited
3 mU/ml of activity and the specific activity of pure pro-
tein was calculated to be 0.21 mmol of glycopeptide de-
graded/mg protein/min.
To rigorously prove that the reaction product detected
by Png1p was formed by a de-N-glycosylation reaction,
further product analysis was performed using the purified
Png1(His6)p. This was particularly important because the
paper chromatographic method only detects the removal
of the glycan from peptide, which could be catalyzed by
another type of endoglycosidase such as endo-b-N-acetyl-
Figure 2. Schematic representation of chromosome XVI of S.
cerevisiae and the marker genes used in this study. The PNG1 lo-
cus determined in this study is also indicated.
Figure 3. Assay of PNGase
activity in an E. coli cell-free
extract. The E. coli strain
used was BL21(DE3)pLysS.
Shown is a paper chromato-
gram of the reaction product
formed after 10 min of incu-
bation of the E. coli extract
with labeled substrate. (lane
1) E. coli extract with pET-
28b-PNG1; (lane 2) E. coli
extract with pET-28b (control
vector); and (lane 3) E. coli
extract without vector. The
extra minor band indicated
with an asterisk was con-
firmed to be [14C]Leu-Asp by
analysis by paper electrophoresis, as described earlier (Kitajima,
et al., 1995), and may be derived from a contaminating protease
activity in the E. coli extract. In fact, this degradation product
represents a fraction of the product of PNGase activity because
the second amino acid in the substrate was converted into Asp in-
stead of remaining as Asn. P, de-N-glycosylated product ([14C]-
Leu-Asp-Asn-Ser-Arg); and S,  substrate ([14C]-Leu-Asn(Glc
NAc5Man3Gal3)-Asn-Ser-Arg). For details, see Materials and
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glucosaminidase (Suzuki et al., 1995). For this pur-
pose, paper electrophoresis analysis was performed since
this method separates products primarily based on their
charge and will detect the conversion of the glycosylated
Asn into an Asp residue. This, together with the paper
chromatography, has been established as the method to
detect PNGase activity in cellular tissues (Kitajima et al.,
1995). For a reference sample, PNGase F-deglycosylated
peptide was used. Indeed, the reaction product from puri-
fied Png1(His6)p gave the same mobility with the authen-
tic deglycosylated peptide formed by PNGase F using pa-
per electrophoresis as well as paper chromatography (Fig.
4, C and D). This clearly demonstrates that Png1p pos-
sesses PNGase activity.
To determine if there was a correlation of PNG1 expres-
sion and PNGase activity, PNG1 was expressed using
CEN (pRS316; single copy) or 2-micron (YEp352; multi-
copy) plasmids in the png1D strain (TSY146). As shown in
Fig. 5 A, both PNG1 constructs complemented the defect
of PNGase activity in png1D strain. A time course experi-
ment (Fig. 5 B) showed that the PNGase activity was four-
to fivefold higher in cells expressing Png1p with the 2-micron
plasmid than that with CEN plasmid, indicating a clear-cut
correlation of PNGase activity with the level of expression
of PNG1.
To assess the reactivity of Png1p toward glycoproteins
in vitro, three glycoproteins (ribonuclease B, ovalbumin,
and carboxypeptidase Y) were examined. In sharp con-
trast to bacterial PNGase F, there was no detectable de-
N-glycosylated product found by SDS-PAGE analysis,
even after the proteins were heat treated to partially dena-
ture them (data not shown).
Deletion of PNG1 Causes a Delay in the Degradation of 
a Mutant Form of Carboxypeptidase Y
A phenotypic difference between wild-type and png1D
cells was not detected in terms of growth rate or viability
(data not shown). Because soluble PNGase activity has
been proposed to be involved in proteasome-dependent
degradation in the cytosol in mammalian cells, the effect
of deletion of PNG1 on the degradation of a mutant car-
boxypeptidase Y protein, CPY* (Hiller et al., 1996), was
examined. CPY* is a well characterized mutant glycopro-
tein that does not fold correctly and, therefore, is a sub-
strate for proteasomal degradation in yeast. We con-
structed strains having the prc1-1 allele, which encodes
CPY*, in png1D and isogenic wild-type strains. The half-
life of CPY* was compared in the two strains by pulse–
chase experiments. As shown in Fig. 6 (A and B), the
PNG1 gene is not required for CPY* degradation. How-
ever, a distinct delay in degradation was seen with the
png1D strain, showing an increase in the half-life of the CPY*
protein to 46 min compared with 26 min in the PNG1
strain. No differences were observed in the vesicular trans-
port of CPY wild-type protein in png1D and isogenic wild-
type strains (data not shown).
In mammalian cells, the involvement of PNGase in pro-
Figure 4. Purification of (His6)-
tagged Png1p (Png1(His6)p) and
reaction product analysis of
[14C]asialofetuin glycopeptide I
with it. E. coli extract overex-
pressing Png1(His6)p was incu-
bated with TALON metal affin-
ity resin, transferred to a 3-ml
gravity flow column, and the elu-
tion was carried out as described
in Materials and Methods.  (A)
Elution profile of each fraction
was analyzed by 10% SDS-PAGE. 10 ml of each fraction was applied for the analysis. The position of migration of Png1(His6)p is indi-
cated. Molecular masses indicated are based on prestained molecular mass marker standards (Bio-Rad). (B) Detection of PNGase ac-
tivity in each elution fraction. The activity in each fraction was measured after 16-h incubation of reaction mixture at room temperature.
(C and D) Analysis of reaction products produced by incubation of [14C]asialofetuin glycopeptide I with purified Png1(His6)p using (C)
paper chromatography and (D) paper electrophoresis. (lane 1) [14C]asialofetuin glycopeptide I; (lane 2) reaction product formed by
Png1(His6)p; and (lane 3) reference reaction product formed by PNGase F. The PNGase-deglycosylated product, [14C]-Leu-Asp-Asp-
Ser-Arg, is indicated by asterisks.
Figure 5. Complementation of the defect of PNGase activity in
png1D cells by plasmids bearing PNG1. (A) PNGase activity as-
say in extract of TSY146 (png1D) cells with pRS316 (negative
control; lane 1), pRS316-PNG1 (CEN plasmid bearing PNG1;
lane 2) and YEp352-PNG1 (2-micron plasmid bearing PNG1).
(B) Time course study of PNGase activity in TSY146 cells bear-
ing pRS316-PNG1 (CEN, x) or YEp352-PNG1 (2 microns; d).
At the indicated times, an aliquot of reaction mixture was re-
moved and PNGase activity was quantitated using paper chroma-
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teasomal degradation was first indicated by the appear-
ance of de-N-glycosylated degradation intermediates in
the presence of proteasome inhibitors (Wiertz et al.,
1996a). In yeast, these inhibitors are ineffective because
they cannot enter yeast cells unless the cells have a muta-
tion in the ERG6 gene, which causes the cells to have in-
creased permeability to a variety of exogenous compounds
(Graham et al., 1993). Previously, it has been shown that
MG-132, a specific inhibitor of the proteasome, inhibits
the degradation of short-lived proteins in an erg6 mutant
background (Lee and Goldberg, 1996). Because the effect
of the MG-132 proteasome inhibitor on CPY* degrada-
tion had not been examined, we analyzed CPY* destruc-
tion in the presence of this inhibitor using the erg6D strain.
As shown in Fig. 6 C, we observed a moderate, but repro-
ducible increase in the half-life for this protein in the pres-
ence of the proteasome inhibitor in PNG1 cells (t1/2 5 27
min without MG-132 versus 47 min with MG-132). In
sharp contrast to the PNG1 cells, there was no effect of the
proteasome inhibitors on the degradation of CPY* in the
png1D strain (t1/2 5 48 min without MG-132 versus 49 min
with MG-132; Fig. 6 C). Thus, the lowered rate of degrada-
tion of CPY* (t1/2 5 46–48 min) was not further decreased
by the addition of the proteasome inhibitor. No de-N-gly-
cosylated intermediates were observed, even in the pres-
ence of MG-132, since there was no change in the position
of migration of CPY* with and without the proteasome in-
hibitor and, in both cases, the CPY* was susceptible to
PNGase F digestion (data not shown).
Png1-GFPp Is Found in Both the Nucleus and
the Cytosol
Although in earlier studies most of the PNGase activity in
a variety of tissues and cells was recovered in the soluble
(cytosolic) fraction after subcellular fractionation (Suzuki
et al., 1993, 1997, 1998b), the precise subcellular location
of the soluble PNGase is still unclear. To localize Png1p in
yeast, the green fluorescent protein (GFP) was fused to
the COOH terminus of Png1p. Western blotting using
anti-GFP mAbs (Fig. 7 A) revealed the absence of immu-
noreactivity in the png1D strain (TSY146), whereas a sin-
gle protein of the expected size (70.5 kD) was detected
when TSY146 was transformed with a plasmid containing
the PNG1-GFP gene. TSY146/pPNG-GFP exhibited PNG-
ase activity, confirming that the Png1-GFPp is enzymati-
cally active (data not shown).
The distribution of Png1-GFPp was analyzed after fixa-
tion and staining of the nuclei with DAPI. As seen in Fig. 7
(B and C), the signal was distributed throughout the cells
Figure 6. Effect of png1D on CPY* degradation. Radiolabeled
CPY*, prepared as described in Materials and Methods, was ana-
lyzed by 7.5% SDS-PAGE, and the labeled protein was visual-
ized using a PhosphorImager. (A) CPY* from TSY147 (BY4742
prc1-1); and (B) CPY* from TSY149 (BY4742 prc1-1 png1D::
KanMX4). (C) Effect of proteasome inhibitor, MG-132, on the
degradation of CPY*. The CPY* recovered by immunoprecipita-
tion at the times indicated was quantitated. PI, proteasome inhib-
itor (MG-132). The values are the average of three separate ex-
periments and standard errors are indicated. For details, see
Materials and Methods.
Figure 7. Western blot analysis and subcellular localization of Png1p-GFP fusion protein (Png1-GFPp). (A) Western blotting of Png1-
GFPp using anti-GFP antibody. (lane 1) TSY146 cells with pRS316 (CEN URA3; Sikorski and Hieter, 1989) as a negative control; (lane
2) TSY146 with pPNG1-GFP (URA3); and (lane 3) TSY146 with pGFP-C-FUS (Niedenthal et al., 1996) as a positive control of GFP
protein. (B) Localization of Png1-GFPp in S. cerevisiae. (C) DAPI staining of the same image shown in B.Suzuki et al. PNGase Gene in Saccharomyces cerevisiae 1047
with a somewhat stronger signal in the nucleus. Much less
staining was observed in large vesicles, which presumably
represent vacuoles. These results imply that the protein is
localized in the cytosol and nucleus, but is not present in
the vesicular compartment.
Sequence Comparison Reveals that the Png1p Is a 
Highly Conserved Protein in Eukaryotes
To determine the distribution of proteins homologous to
yeast Png1p in other eukaryotes, sequence searches were
performed using nucleotide/protein databases. By using S.
cerevisiae Png1p sequence as a query, we found several
Png1p homologues (E , 6e29) in various eukaryotes (Ta-
ble IV). After determining the complete sequence of an
IMAGE clone (AI019191), we used it to further carry out
EST database surveys and identified several EST clones
that consisted of complete or partial ORFs from human
(IMAGE clone ID 1316890 from Research Genetics and
EST clone accession No. 97076 from ATCC), mouse (IM-
AGE clone ID 948982), D. melanogaster (IMAGE clone
ID LD46390), and C. elegans (yk491.h3; a gift from Dr.
Yuji Kohara). Fig. 8 shows the sequence alignment of S.
cerevisiae Png1p with S. pombe, C. elegans, D. melano-
gaster, mouse, and human homologues. The homologues
in higher eukaryotes were found to have more extended
sequences at both the NH2 and COOH termini than either
S. cerevisiae or S. pombe Png1p (Fig. 8). However, align-
ment of the determined sequences revealed a highly con-
served core domain present in all eukaryotes examined
(Fig. 8). The sequence analysis of png1-1 allele revealed
that the png1-1 was due to a point mutation of a highly
conserved His residue (residue 333 in Fig. 8), which was
changed to Tyr, suggesting the importance of this His resi-
due on catalytic activity of Png1p.
Discussion
The functional importance of de-N-glycosylation in cellu-
lar processes by PNGase was first proposed based on stud-
ies in fish oocytes and embryos (Inoue, 1990; Seko et al.,
1991). Since then, interest in the biological function of PNG-
ase in somatic eukaryotic cells has grown (Suzuki et al.,
1994b, 1995; Berger et al., 1995) and the involvement of
mammalian cytosolic PNGases in proteasome-mediated
degradation has been proposed (Wiertz et al., 1996a,b).
However, because the functional importance of the de-
N-glycosylation reaction remained unclear in detail, we
undertook to study this enzyme in the single cell eukary-
ote, S. cerevisiae. In our initial study (Suzuki et al., 1998b),
we demonstrated the presence of PNGase in yeast and
showed that it had many of the properties reported for
PNGase from higher eukaryotes. In this study, we report
the identification of a PNGase activity-defective yeast mu-
tant (png1-1) strain. Using this strain, we carried out vari-
ous genetic approaches that led to the identification of the
PNG1 gene (YPL096w). PNG1 was definitively shown to
encode PNGase by carrying out the analysis of reaction
product of [14C]asialofetuin glycopeptide I with purified
Png1p overexpressed in E. coli. Correlation of the expres-
sion level of PNG1 gene and PNGase activity was also
confirmed through a complementation experiment using
the plasmid borne PNG1 gene. PNG1 encodes a soluble
protein with no apparent signal sequence. No homologues
are present in the S. cerevisiae genome, indicating that the
gene is not redundant in yeast. This observation is con-
sistent with the finding that deletion of PNG1 abolishes
PNGase activity. Sequence analysis of png1-1 revealed that
the gene encoded a full-length protein corresponding to
Png1p with a single mutation of His 218 to Tyr (Fig. 8; res-
idue No. 333), indicating the importance of this His resi-
due in catalytic activity. Indeed, this His residue was found
to be conserved for all eukaryotes examined (Fig. 8).
Because the mutant strain did not have a detectable
phenotype after several backcrosses to wild-type strains,
the isolation of the gene by complementation was prob-
lematic. Moreover, the amount of Png1p in yeast cells
seems to be very limited; for example, we can detect the
PNGase activity only with a highly sensitive method using
radioactive glycopeptide as a substrate, and it still requires
12–16 h to detect the activity when the yeast extract is used
as an enzyme source (Suzuki et al., 1998b). Indeed, the
Table IV. S. cerevisiae Png1p-related Sequences Found in Sequence Database*
Accession no. Definition E value
AL031852 SPBC1709; Schizosaccharomyces pombe chromosome II cosmid c1709 5e250
AI856765 sb41h09.y1 Gm-c1014 Glycine max cDNA clone Genome System clone ID: Gm-c1014-282 59 1e233
AI019191 ub20e10.r1 Soares 2NbMT Mus musculus cDNA clone IMAGE:1378314  2e229
AI491330 486017B11.x2 486 - leaf primordia cDNA library from Hake lab Zea mays cDNA 5e228
AC008339 BACR13P06; Drosophila melanogaster chromosome II BAC clone D917 3e227
AL117201 CEY53H1C; Caenorhabditis elegans chromosome I cosmid Y53H1C 6e222
Z28729 HSB85D121 Stratagene human skeletal muscle cDNA library, cat. #936215. Homo sapiens cDNA clone 85D12 1e221
AI392526 NCSC1A9T3 Subtracted Conidial Neurospora crassa cDNA clone SC1A9 2e216
AA139963 mq92e01.r1 Stratagene mouse heart (#937316) Mus musculus cDNA clone IMAGE:586200 7e216
AA107311 mp06d11.r1 Life Tech mouse embryo 8 5dpc 10664019 Mus musculus cDNA clone IMAGE:568437 1e212
AA786911 m7b03a1.r1 Aspergillus nidulans 24 h asexual developmental and vegetative cDNA lambda zap library 
Emericella nidulans cDNA clone m7b03a1
2e212
AB023033 Arabidopsis thaliana genomic DNA, chromosome V, TAC clone: K6M13 5e29
Z81552 Caenorhabditis elegans cosmid chromosome I cosmid F56G4 6e29
*Data are from tblastn search using the complete protein sequence of S. cerevisiae Png1p as a query. Results are from NCBI database except for AC008339, which was only found
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PNG1 turns out to have significantly low codon usage
(codon bias, 20.032), indicating that it would have been
extremely difficult to isolate pure Png1p. Therefore, an
approach using various genetic methods, as well as appli-
cation of the yeast genome sequence and the single ORF
deletion strains that are commercially available was cru-
cial in identification of the PNG1 gene.
Whereas the purified enzyme using hexahistidine tag ex-
hibited high PNGase activity toward the glycopeptide sub-
strate (z0.21 mmol/mg protein/min), reactivity toward gly-
coproteins could not be detected in vitro. This is consistent
with the finding that the soluble PNGase, isolated and pu-
rified from mammalian cells, also does not act on glyco-
proteins in vitro (Suzuki et al., 1994a). These observations
are reminiscent of the fact that the 20S proteasome can
only act primarily on small peptide substrates in vitro, and
it has been widely supposed that the function of the 19S
ATPases is to unwind protein substrates for them to be
substrates for this proteolytic complex (Rubin and Finley,
1995; Wenzel and Baumeister, 1995). The result of the in-
ability of PNGase to act on glycoproteins in vitro may in-
dicate that additional factors are required (as is the case of
20S proteasome) for this enzyme to recognize glycopro-
teins as substrates in vivo. Currently, we are studying this
possibility.
One explanation for the lack of a detectable phenotype
in the png1D strain as well as png1-1 strain is that the en-
zyme is not required unless a large amount of misfolded
glycoprotein is being produced by the yeast cells. We
found that in png1D cells the rate of degradation of an in-
correctly folding mutant protein, CPY* (Hiller et al., 1996)
was reduced compared with wild type, suggesting that the
gene is at least, to some extent, involved in ER-associated
proteasomal degradation. Although our result does not
Figure 8. Comparison of sequences of Png1p and
its homologues. ScPng1p, S. cerevisiae Png1p;
hPng1p, human Png1p homologue (partial; se-
quence was determined from EST clone 97076
[ATCC] and IMAGE clone ID 1316890);
mPng1p, mouse Png1p homologue (sequence
determined from IMAGE clone 948982);
DmPng1p,  D. melanogaster Png1p homologue
(sequence determined from IMAGE clone
LD46390); CePng1p, C. elegans Png1p homo-
logue (sequence determined from yk491h3 and
the Entrez database CAB57916); and SpPng1p,
S. pombe Png1p homologue (sequence obtained
from the Entrez database CAA21253). Asterisks
represent the conserved cysteine residues in
CXYC motifs. The conserved His residue that
was found to be mutated to Tyr in the png1-1 al-
lele is also indicated (#). Numbering is based on
the mPng1p sequence.Suzuki et al. PNGase Gene in Saccharomyces cerevisiae 1049
rule out the possibility that the delay in degradation of
CPY* is due to an indirect effect rising from the deletion
of Png1p, it is of interest that a number of genes required
for this degradation process are nonessential and do not
exhibit detectable growth defects under the experimental
conditions used (Plemper and Wolf, 1999). These observa-
tions imply that the ER quality control machinery seems
dispensable under standard laboratory culture conditions,
at least in yeast, despite the fact that this process has
known to be closely associated with a number of genetic
disorders in mammals (Plemper and Wolf, 1999).
When the proteasome inhibitor, MG-132, was added to
cells under conditions that are known to inhibit proteaso-
mal degradation (Lee and Goldberg, 1996; Loayza et al.,
1998), partial inhibition of degradation of CPY* was ob-
served. This degree of inhibition is consistent with the pre-
vious observations on the rate of CPY* degradation using
mutated proteasome subunits; with various mutants the
t1/2 was increased to 2–2.5-fold, but in no case was degrada-
tion completely blocked (Hiller et al., 1996). Partial inhibi-
tion by the proteasome inhibitor may result because this
compound is not effectively taken up by yeast as com-
pared with animal cells (Lee and Goldberg, 1998), or it
may be the result of a yet uncharacterized alternative pro-
tein degradation system that is not sensitive to this inhibi-
tor. In this connection, it is interesting to note that occur-
rence of a novel proteolytic complex that can compensate
for the essential function of the proteasome recently has
been reported in mammalian cells as well as in S. pombe
(Glas et al., 1998; Geier et al., 1999; Osmulski and Gaczyn-
ska, 1999).
We were unable to detect a synergistic effect on CPY*
degradation when the proteasome inhibitor was added to
the PNGase deletion strain. Unlike mammalian cells, with
PNGase1 yeast cells to which proteasome inhibitors had
been added, we were unable to detect the accumulation of
de-N-glycosylated protein intermediates. This finding may
mean that de-N-glycosylation is a rate-limiting step for
proteasome-mediated degradation in yeast, and it may not
be possible to detect the de-N-glycosylated intermediate
under conditions of incomplete inhibition of proteasome
activity. In addition, the lack of de-N-glycosylated protein
intermediates in yeast may indicate that the level of PNG-
ase activity in mammalian cells may be much higher than
that in yeast. This hypothesis is consistent with the finding
that when small glycopeptides are exported out of the ER
to the cytosol, de-N-glycosylation occurs immediately in
mammalian cells, but not in yeast (Römisch and Ali, 1997;
Suzuki et al., 1998b). Since PNGase did not affect glyco-
peptide export from the ER to the cytosol (Suzuki, T., and
W.J. Lennarz, unpublished observations), it is not likely
that PNGase is directly involved in the translocation of
misfolded proteins from the ER to the cytosol. Rather, it
seems that the absence of a PNGase defect somehow
slows down proteasomal degradation after the proteins
are translocated from the ER to the cytosol or in the case
of yeast, to the nucleus.
Although most of the soluble PNGase activity has been
described as cytosolic or cytoplasmic, there still is contro-
versy about the precise localization of PNGase in cells
(Weng and Spiro, 1997). The primary structure indicates
that there is no apparent signal or hydrophobic sequence
that could represent a transmembrane domain. This is
consistent with the hypothesis that the soluble PNGase
does not enter the secretory pathway and, therefore, re-
mains in the cytosol or a topologically equivalent compart-
ment (i.e., the nucleus). Subcellular localization studies of
Png1-GFPp in S. cerevisiae demonstrated that, although
most of the protein is localized in the cytosol, a fraction of
the protein is concentrated in the nucleus. At this point, it
is not clear if the nucleus-associated protein represents a
membrane-associated type of PNGase, which has been de-
scribed earlier in animal cells (Suzuki et al., 1997; Weng
and Spiro, 1997). It is also interesting to note that, unlike
multicellular eukaryotes in which proteasomes are abun-
dant in the cytosol, in S. cerevisiae, the proteasome is al-
most exclusively localized in the nucleus (Russell et al.,
1999). Since, as discussed above, the soluble PNGase ac-
tivity may be associated with the proteasomal degradation
pathway, the higher concentration of Png1p in the nucleus
may indicate colocalization and possible interaction be-
tween PNGase and the proteasome machinery in yeast
cells.
A careful survey for Png1p homologues in various data-
bases as well as additional sequences of EST clones from
various organisms revealed homologues in mammals,
plants, insects, nematodes and fungi. These findings dem-
onstrate that this gene is highly conserved evolutionarily
throughout eukaryotes. In fact, we have observed PNGase
activity when the mouse homologue of Png1p is expressed
in png1D yeast cells, establishing that the mouse homo-
logue is indeed a functional PNGase (Suzuki, T., and W.J.
Lennarz, unpublished results). Furthermore, Northern
analysis using mouse PNG1 cDNA as a probe revealed the
presence of mRNA in all tissues tested, which is consistent
with the biochemical findings of a wide tissue distribution
of PNGase activity in mice (Kitajima et al., 1995). Al-
though the functional role of Png1p in cellular processes
still remains unclear, the ubiquitous occurrence of this
protein in eukaryotes strongly suggests functional signifi-
cance in certain fundamental biological processes. Finding
mutants that are synthetically lethal with png1D  might
provide insight into the function of Png1p, and this line of
study is currently underway.
As shown in Fig. 8, the S. cerevisiae and S. pombe PNG-
ases have a core sequence that is highly homologous
(amino acid residues 106–362 in ScPng1p) to that found
in homologues in higher eukaryotes. In this core, two
conserved cysteine residues form CXYC motifs (aster-
isks). This motif, which is found in the protein disulfide
isomerase family, is known to be oxidized to form disulfide
bonds. This finding is of interest in view of the fact that re-
ducing reagents such as DTT are required for detection of
the PNGase enzyme in in vitro assays (Suzuki et al., 1994a,
1997, 1998b; Kitajima et al., 1995). Perhaps these con-
served cysteine residues are important for its catalytic ac-
tivity. It is also interesting to note that the C. elegans ho-
mologue has an apparent thioredoxin-like domain in its
NH2 terminus region (66% homologous to the S. cerevisiae
TRX2 gene), and the active site for thioreductase activity
(WCGPC) is completely conserved. These findings sug-
gest that the action of PNGase in the cytosol (or nucleus)
may somehow be regulated by redox potential. Redox po-
tential is known to be important for ER-associated degra-The Journal of Cell Biology, Volume 149, 2000 1050
dation in mammalian cells (Young et al., 1993; Tortorella
et al., 1998), although, thus far, not much is known about
its mechanism. Clearly, now that the primary structure of
PNGase is known, future studies involving a structure–
function approach should answer a number of important
questions about the biological importance of this enzyme.
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